期刊论文详细信息
International Journal of Molecular Sciences
Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
Karin Zins2  Anita Thomas2  Trevor Lucas2  Mouldy Sioud1  Seyedhossein Aharinejad2 
[1] Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo N-0310, Norway; E-Mail:;Laboratory for Molecular Cellular Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna 1090, Austria; E-Mails:
关键词: prostate cancer;    placental growth factor;    xenograft model;    tumor-host interaction;    tumor angiogenesis;   
DOI  :  10.3390/ijms140917958
来源: mdpi
PDF
【 摘 要 】

The growth and vascularization of prostate cancer is dependent on interactions between cancer cells and supporting stromal cells. The primary stromal cell type found in prostate tumors is the carcinoma-associated fibroblast, which produces placental growth factor (PlGF). PlGF is a member of the vascular endothelial growth factor (VEGF) family of angiogenic molecules and PlGF mRNA levels increase after androgen deprivation therapy in prostate cancer. In this study, we show that PlGF has a direct dose-dependent proliferative effect on human PC-3 prostate cancer cells in vitro and fibroblast-derived PlGF increases PC-3 proliferation in co-culture. In xenograft tumor models, intratumoral administration of murine PlGF siRNA reduced stromal-derived PlGF expression, reduced tumor burden and decreased the number of Ki-67 positive proliferating cells associated with reduced vascular density. These data show that targeting stromal PlGF expression may represent a therapeutic target for the treatment of prostate cancer.

【 授权许可】

CC BY   
© 2013 by the authors; licensee MDPI, Basel, Switzerland

【 预 览 】
附件列表
Files Size Format View
RO202003190033582ZK.pdf 848KB PDF download
  文献评价指标  
  下载次数:49次 浏览次数:3次